Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.80 |
| ▸ | HPGD | P15428 | 2/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.80 |
| ▸ | CES1 | P23141 | 1/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.80 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.67 |
| ▸ | ERCC5 | P28715 | 2/20 | 0.67 |
| ▸ | FEN1 | P39748 | 2/20 | 0.67 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28173667 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL5142647 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL27897747 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL28519781 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL527869 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| Ammonia Solution, Strong SCHEMBL14935544 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL28418364 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL27915275 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL5144883 | 0.97 | CYP3A4 (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL441330 | 0.97 | KMT2A (0.76) | KMT2AMEN1CYP3A4HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080382-A | Isosorbide type polycarbonate and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12427714-B2 | Functionalized product fabricated from a resin comprising a functional component and a polymeric resin, and method of making the same | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-09-30 | — | — | US | claimed |
| US-12360294-B2 | 3D printed graded refractive index device | CARLETON UNIVERSITY (CA) | 2025-07-15 | — | — | US | claimed |
| CN-120058585-A | Dimercapto conjugate of active allyl alcohol acetate, and preparation method and application thereof | 南京工业大学 | 2025-05-30 | — | — | CN | claimed |
| EP-3674376-B1 | CATIONIC ELECTRODEPOSITION COMPOSITION AND METHOD FOR ELECTRODEPOSITION | KANSAI PAINT CO LTD (JP) | 2024-12-11 | — | — | EP | claimed |
| US-12043764-B2 | Cationic electrodeposition coating composition and method for electrodeposition coating | KANSAI PAINT CO., LTD. (JP) | 2024-07-23 | — | — | US | claimed |
| US-20240124910-A1 | RIBOSOME-MEDIATED POLYMERIZATION OF NOVEL CHEMISTRIES | NORTHWESTERN UNIVERSITY | 2024-04-18 | — | — | US | claimed |
| US-20230373962-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF BIRMINGHAM (GB) | 2023-11-23 | — | — | US | claimed |
| CN-117098815-A | Rubberized asphalt composition having acrylic copolymer | 巴斯夫欧洲公司 | 2023-11-21 | — | — | CN | claimed |
| CN-113582912-B | Preparation method of optically pure lobelin hydrochloride and enantiomer thereof | 广东药科大学 | 2023-09-01 | — | — | CN | claimed |
| EP-0253598-A2 | Cement dispersion agent | LION CORPORATION (JP) | 1988-01-20 | — | — | EP | claimed |
| EP-0079134-B1 | STEREOSPECIFIC SYNTHESIS OF 5-PHENYL-2S-PENTANOL | PFIZER INC. (US) | 1985-02-06 | — | — | EP | claimed |
| US-4477636-A | UNSATURATED POLYESTERS; HEAT RESISTANCE; HIGH STRENGTH | MUROI SOICHI (JP) | 1984-10-16 | — | — | US | claimed |
| US-4412958-A | Stereospecific synthesis of 5-phenyl-2S-pentanol | PFIZER INC. (US) | 1983-11-01 | — | — | US | claimed |
| EP-0079134-A1 | Stereospecific synthesis of 5-phenyl-2S-pentanol | PFIZER INC. (US) | 1983-05-18 | — | — | EP | claimed |
| US-4369038-A | Transfer-printing paper, its manufacture and uses | CIBA-GEIGY LTD. (CH) | 1983-01-18 | — | — | US | claimed |
| EP-0017602-B1 | 2-PHENYL-4-PYRONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | RHONE-POULENC AGROCHIMIE (FR) | 1982-10-20 | — | — | EP | claimed |
| US-4165412-A | SALTS OF TERTIARY AMINE AND ALPHA-SUBSTITUTED CARBOXYLIC ACIDS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1979-08-21 | — | — | US | claimed |
| US-4126577-A | COMPOUND OF VANADIUM OR NIOBIUM COMPLEXED WITH NITRIC OXIDE AND A SELECTED COMPLEXING AGENT | PHILLIPS PETROLEUM COMPANY (US) | 1978-11-21 | — | — | US | claimed |
| US-3962231-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1976-06-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373962-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | PCNA, DDX1, DDX18 | KMT2A 3866/4885MEN1 230/4885CYP3A4 2902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.